SMLR Stock Overview
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.
Semler Scientific, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$31.15|
|52 Week High||US$99.99|
|52 Week Low||US$26.70|
|1 Month Change||-27.56%|
|3 Month Change||-29.76%|
|1 Year Change||-67.88%|
|3 Year Change||-27.24%|
|5 Year Change||313.13%|
|Change since IPO||345.64%|
Recent News & Updates
Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's DowngradeMar 08
Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?Mar 02
Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They SeemNov 12
It Looks Like The CEO Of Semler Scientific, Inc. (NASDAQ:SMLR) May Be Underpaid Compared To PeersOct 15
There's Reason For Concern Over Semler Scientific, Inc.'s (NASDAQ:SMLR) Massive 28% Price JumpOct 14
|SMLR||US Medical Equipment||US Market|
Return vs Industry: SMLR underperformed the US Medical Equipment industry which returned -16.8% over the past year.
Return vs Market: SMLR underperformed the US Market which returned -14.8% over the past year.
|SMLR Average Weekly Movement||12.4%|
|Medical Equipment Industry Average Movement||8.9%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: SMLR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: SMLR's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups.
Semler Scientific, Inc. Fundamentals Summary
|SMLR fundamental statistics|
Is SMLR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SMLR income statement (TTM)|
|Cost of Revenue||US$5.24m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||1.84|
|Net Profit Margin||23.18%|
How did SMLR perform over the long term?See historical performance and comparison